yes, we care · genuine care we genuinely care for patients everywhere. we have been able to build...
Post on 29-Jun-2020
3 Views
Preview:
TRANSCRIPT
Company Profile
2020
Yes, We Care
Company Profile | 2020
On behalf of the Board of Directors of EIPICO, I would like to present to you our company profile which I trust you will find as a reliable, useful and valuable source of information.
Our motto, “Yes, We Care”, reflects our assiduous effort and ongoing striving to assist healthcare systems, whether domestically or internationally, by providing high quality pharmaceutical products at reasonable prices.
EIPICO was the leading pharmaceutical company in Egypt to apply Good Manufacturing Practice (GMP), the system for ensuring that products are consistently produced and controlled according to quality standards.
Message from the Chairman of the Board of Directors
Company Profile | 2020
EIPICO is, currently, one of the leading Egyptian pharmaceutical companies, in terms of production and sales, in the local market. It is the leading company in pharmaceutical exports, capturing a 21% share of the total Egyptian pharmaceutical export market.
Our product portfolio comprises more than 400 products, covering more 24 therapeutic classes, including: antibiotics, antivirals, anaesthetics, as well as, ophthalmic, cardiovascular, gastrointestinal, genitourinary and respiratory drugs and many more.
Through generating innovative entrepreneurial ideas, meticulous planning, and with the support of hardworking, enthusiastic, diligent, high-performance teams, working in tandem, and committed to their duties, we shall continue to fulfill our mission of expanding our production of high quality products, to satisfy the needs of the medical community.
Message from the Chairman of the Board of Directors
Company Profile | 2020
EIPICO will continue to improve its efficiency in every aspect and will continuously endeavor for evolution, saving no effort to meet the current and future expectations of the healthcare systems and to contribute to the healthcare development of our country.
Finally, I would like to express my deepest thanks to our shareholders and to the medical and pharmaceutical professionals for their trust, our partners and suppliers for their support and our employees for their relentless efforts to maintain our position as a leading pharmaceutical company.
Message from the Chairman of the Board of Directors
Chief Executive Officer
Company Profile | 2020
Our Vision
To be One of the World's Leading Pharmaceutical Companies
Company Profile | 2020
Providing Highest Quality Medicines at affordable prices for Patients.
Providing our Investors with a Superior Rate of Return.
Maintaining an Inspiring Work Environment for our Employees.
Our Mission
Our Core ValuesGenuine CareWe genuinely care for patients
everywhere. We have been able to
build trust in our products and we
are committed to exerting all efforts
to keep the healthcare
professionals' and patients'
continuous trust.
Product QualityWe work on the quality of our
products to ensure their efficacy
and safety are up to the highest
standards. Highest quality besides
respect for the environment are
among our priorities.
InnovationEIPICO has a climate that helps
creativity and innovation which
eventually leads to the
continuous development of our
business.
Integrity
We believe that doing our
jobs with integrity and
conscientiousness is the
sole key to great
achievements.
TeamworkWe build high-performance
teams working harmoniously
together to achieve assigned
missions with the best possible
results.
High PerformanceOur performance is the practical
way to express our commitment
to the principles and duties of
work. We always aim at
improving our performance to
reach the highest levels.
FairnessWe work on the balance of justice,
equity and rights distribution, as we
believe that these principles will
guarantee that our staff will save no
efforts to achieve our business goals.
EmpowermentEIPICO gives the opportunity and
confidence to its staff through
authorization and delegation to
assume responsibilities and
contribute to the overall company's
success.
LoyaltyThe individual affiliation of EIPICO
stems from the company's social
contributions to the individual and gives
the members of EIPICO pride and
belonging to their work in the company.
Company Profile | 2020
Company Profile | 2020
EIPICO is committed to its social responsibility and is currently contributing to the
"100 Million Healthy Lives" National Campaign aiming at elimination of hepatitis C
virus (HCV).
EIPICO donated 15,000 packs of Episovir 400 mg Tablets to the Ministry of Health
in order to support all national efforts and achieve Egypt’s dream.
Our Responsibilities
Egypt to be Free from Virus C by 2020
Company Profile | 2020
EIPICO was established in Tenth of Ramadan City in 1980, with a capital of L.E. 7 Million,
currently raised to L.E. 1500 Million, as an Egyptian public shareholder company
operating according to the Investment Law (No. 43/1974 modified by Law No. 32/1977).
EIPICO started production in 1985 as the Leading Company in Egypt and the Middle East
and North Africa (MENA) Region, to produce pharmaceutical products according to Good
Manufacturing Practice (G.M.P.) regulations, with the aim of providing local and
international markets with high quality products at affordable prices.
EIPICO has 2 Plants built over a surface area of 120 thousand square meters, which fully
operate in compliance with cGMP regulations, to assure the safety and efficacy of the
pharmaceutical products.
EIPICO … Yes We Care
Company Profile | 2020
EIPICO is unique with its 9 sterile areas, which are the Largest and Most Advanced, in
Egypt and in the MENA Region.
EIPICO has the First Biotechnology and Genetic Engineering Research Center in Egypt
manufacturing biopharmaceutical products.
EIPICO manufactures more than 400 Pharmaceutical Products covering 24 Therapeutic
Groups.
EIPICO holds License Agreements with a group of international pharmaceutical
companies to produce their products locally.
EIPICO is currently the Largest Provider of Antibiotics, Lyophilized Products and
Spansule Capsules to the Egyptian market.
EIPICO … Yes We Care
Company Profile | 2020
EIPICO is ranked Number 1 in the Egyptian Ophthalmic Market, by units.
EIPICO is ranked Number 1 in Egyptian Exports of Pharmaceutical Products Export,
capturing 21% of Egypt’s Total Exports of Pharmaceutical Products.. It currently
exports to More than 65 Countries around the world, including Arab, African, Asian,
European, Latin American and CIS (Commonwealth of Independent States) countries.
In 2014, the World Health Organization accredited EIPICO, as an approved supplier of
one type of sterile antibiotic products, being the First company in Egypt and in the
Middle East Region.
EIPICO … Yes We Care
Company Profile | 2020Company Profile | 2020EIPICO has been accredited ISO Certificates besides Certificates from European, African, and
Asian Health Authorities.
ISO 9001 ISO 14001 BS OHSAS 18001
EIPICO … Yes We Care
Company Profile | 2020Company Profile | 2020EIPICO has been accredited ISO Certificates besides Certificates from European, African, and
Asian Health Authorities.
The Manufacturing of Medical
Devices (Eye Drops) Certificate
ISO 13485
SFDA Certificate
EIPICO … Yes We Carethe Medicines and Healthcare Products
Regulatory Agency Certificate of U.K.
(MHRA Certificate)
Company Profile | 2020Company Profile | 2020EIPICO has been accredited ISO Certificates besides Certificates from European, African, and
Asian Health Authorities.
Gulf Central Committee for Drug
Registration (GCC Certificate)
EIPICO … Yes We CareMarketing Authorization
Certificate of Romania
Company Profile | 2020Company Profile | 2020EIPICO has been accredited ISO Certificates besides Certificates from European, African, and
Asian Health Authorities.
NAFDAC
CertificateManufacturing Site Registration
Certificate of U.A.E.,
EIPICO … Yes We CareRegistration Certificate of a Foreign
Pharmaceutical Plant of Sudan
Company Profile | 2020
EIPICO… Egypt's Leading Pharmaceutical Company
Factory 2Factory 1
Company Profile | 2020
EIPICO Production Sector is the beating heart of the company's business. Due to its capability and high
performance, the production sector has helped EIPICO to attain its remarkable position in the market, not
only in Egypt but also in the Middle East and North Africa (MENA) Region.
During the last decade, a great upgrading and modifications took place in order to have the best machines
and equipment characterized by high speed, and full automation including robotic systems, in addition to
conversion of all production departments to smart building units with total control of Temperature, Humidity
and Differential pressure between different rooms.
The production system in EIPICO, depends on Total Quality Control with the application of Zero Defect
System.
Production
Company Profile | 2020
2,061,582,500 Tablets
409,650,000 Capsules
354,357,320 Injectable Ampoules
and Vials
27,837,500 Sterile Eye Drops
18,062,500 Ointment and Cream
Tubes
137,600,000 Effervescent Sachets
79,750,000 Syrup and Suspension
Bottles
36,125,000 Suppositories
EIPICO Production Capacity / YearEIPICO is the Leading Egyptian Pharmaceutical Company, in Production, by Units.
EIPICO is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.
Company Profile | 2020
Factory 1 was built in 1980 and renewed using state-of-the-art construction system and materials in
compliance with International Society for Pharmaceutical Engineering (ISPE) regulations assuring
clean environment for all production rooms to provide maximum protection for both products and
personnel.
The site contains several departments for manufacturing of many Dosage Forms.
It includes: the Largest and Most Advanced Sterile Area in Egypt and in the MENA region, separated
areas for Sterile Cephalosporin Antibiotics, Sterile Penicillin Antibiotics and Non Sterile (Oral) Antibiotics
to prevent cross-contamination with up to date containment systems.
Other activities performed in the site include: warehousing, engineering and other administrative functions.
Facilities Factory 1
Company Profile | 2020
Facilities
Sterile Eye Drops Department
Factory 1
Sterile Cephalosporin Antibiotics
Powder Area Department (IMA I)
Sterile Cephalosporin Antibiotics
Powder Area Department (Perry II)
Sterile Penicillin Antibiotics Powder
Area (IMA II) Department
Sterile Penicillin Antibiotics Powder
Area (Perry I) Department
Sterile Ampoules and Vials
Department
Company Profile | 2020
Facilities Factory 1
Soft Gelatin Capsules Department
Liquids Department
Oral Antibiotics Department Solid Dosage Forms (Hard Gelatin
Capsules and Tablets) Department
Semi Solid Department
Company Profile | 2020
Factory 2 was launched in 2013 to fulfill the ever-growing demand of both national and international
markets.
The production facilities have been designed to cope with the latest cGMP and WHO regulations.
The site's main production building contains 6 Manufacturing Departments which are: Sterile
Hormones and Corticosteroids, Sterile Eye Drops, Tablets, Effervescent granules, Syrup and
Suspension and Semi solid Departments.
Facilities Factory 2
Company Profile | 2020
Facilities
Tablets Department
Effervescent Granules
Department
Sterile Eye Drops Department
Semi Solid Department
Sterile Hormones Department
Syrup and Suspension
Department
Factory 2
Company Profile | 2020
Sales and ProductionEGP Millions
15.4 98249
389
677
1100
1668
2475
2747
3,221
20101
262415
755
1123
1762
2593
2877
3,282
-100
400
900
1400
1900
2400
2900
3400
1985 1990 1995 2000 2005 2010 2015 2017 2018 2019
Sales Production
Therapeutic
Lines
Company Profile | 2020
• FLUMOX
• E-MOXCLAV
• NOVACTAM
• E-MOX
• EPICOCILLIN
PENICILLINS
• CEFOTAX
• EPICEPHIN
• CEFIDIME
• CEFOZON
• CEPHRADINE
CEPHALOSPORINS
• CIPROCIN
• EPINOR
• EPICOFLOCIN
QUINOLONES
• TREFLUCAN
• NYSTATIN
ANTIFUNGALS• EPIGENT
AMINOGLYCOSIDES
• EPIZITHRO
MACROLIDES
• EPISOVIR
ANTI-VIRALS
• CETAL
• EPIFENAC
• EPICOTIL
• VASTAFLAM
ANALGESICS &
ANTI-RHEUMATICS
• DOXYDOX
TETRACYCLINES
Company Profile | 2020
• REPAGLINIDE
• GLICLA MR
• PICOLAX
• LACTULOSE
• COLOSPASMIN
• GASTROMOTIL
• MUCOGEL
• EPICOGEL
• GASTROFAIT
• EPIRAZOLE
• EPINOS
ALIMENTARY & METABOLISM
• EPIDRONE
• DEXAMETHASONE
• EPIRELEFAN
• EPIZOLONE-DEPOT
• EPICOPRED
SYSTEMIC CORTICOSTEROIDS
• SILDEN
• EPIMAG
• OXYBIN
• DOSIN
UROLOGICALS
• ATOR
• EPIROVASTIN
• CAPOTRIL
• LOSAZIDE
• RAMPECARDIN
• CO-VASOTEC
• VASOTEC
• EPILAT/RETARD
• REGCOR
• DILTIAZEM
• ATENO/C
• EPIDOPA
• EPITENS
• THROMBO
• ETHANOLAMINE OLEATE
CARDIOVASCULAR
Company Profile | 2020
• SELGON
• BRONCHOPHANE
• NEO-BRONCHOPHANE
• CETAL COLD & FLU
• CONTA FLU
• CETAL SINUS
COUGH &
COLD PREPARATIONS
• BETADERM
• CAMISAN
• NYSTAFORM
• ALLERGEX
• MINOX
DERMATOLOGICALS
• ALZENTAL
• SECNIDAZOLE
• FURAZOL
• EPIQUANTEL
• DISTOCIDE
• KAPECT
• KAPECT COMPOUND
• NIFUROX
ANTIPROTOZOALS &
ANTHELMINTICS &
INTESTINAL ANTI-INFECTIVES
• EPICOZYM
• MINERAVIT
• CEVITIL
• VITAZINC
• EPINOSINE B
• FERRO FOL
• FERROFOLVIT-Z
• FOLIC ACID
• EPOFORM
• VITONA PLUS
VITAMINS & TONICS & ANTIANAEMICS
Company Profile | 2020
• EPIFASI
• EPIGONAL
• PROGESING
SYSTEMIC HORMONES
• EIPICOPHYLLINE
• EIPICOPHYLLINE PHENOBARBITONE
ANTI-ASTHMA
• NORMOLEPSY
• LEVEPSY
• EPIMAZEPINE
• OLAZINE
• RISDAL
• EPISTIGMIN
• HISTOTEC
• FLUTIN
NERVOUS SYSTEM
• POTASSIUM CHLORIDE
• CALCIUM CHLORIDE
• MAGNESIUM SULPHATE
HOSPITAL SOLUTIONS
• THIOPENTAL
ANAESTHETICS
• EPIKAVIT
• PROTAM
SYSTEMIC BLOOD COAGULANT
• EPIRIZINE
• ALLERGEX
• ALLERGEX CAFFEINE
• FEXOSTADINE
ANTIHISTAMINICS
Company Profile | 2020
• NEO MYXIDIN
• EPIDEXONE
• EPISOPT
• EPICROM
• EPIPHENICOL
• EPITAXOL
• XALATREX
• OPTIGENT
EYE & EAR PREPARATIONS
• DEXATROL
• TOBRIN
• DEXATOBRIN
• BENOX
• EPIFENAC
• CIPROCIN
• NEO POL
• NORMO-TEARS
• TIMOLOL
• OLOHISTINE
• NEO MYXIDIN
EYE & EAR PREPARATIONS
• EPIDENT
STOMATOLOGICALS
• NO URIC
ANTI-GOUT
• NOSTAMINE
NASAL DECONGESTANT
“Through generating innovative
entrepreneurial ideas, meticulous
planning, and with the support of
hardworking, enthusiastic, diligent,
high-performance teams, working
in tandem, and committed to their
duties, we shall continue to fulfill our
mission of expanding our
production of high quality products,
to satisfy the needs of the medical
community.”A. Kelani
Company Profile | 2020
Data Matrix
EIPICO implements a Track and Trace Program
based on GS1 DataMatrix, the most widely
used identification system worldwide, to ensure
patient safety and enhance supply chain
efficiency.
Company Profile | 2020
Data
MatrixThe problem of counterfeit drugs is not a new one, but it is a growing issue and
one that cannot be ignored. It has become an increasing global threat over the last few
decades.
EIPICO, as a leading pharmaceutical manufacturer, was of the first to use GS1
DataMatrix which is a system in which the supplier can mark items in the expectation that
all trading partners will be able to read and correctly interpret the data encoded.
This DataMatrix is a (2D or two-dimensional) barcode
which may be printed as a square or rectangular
symbol made up of individual dots or squares.
Company Profile | 2020
Data
MatrixGS1 DataMatrix encodes information such as, but not limited to:Global Trade Item Number (GTIN), a globally unique identification number for medical products, Expiration Date, Batch Number and Serial Number.
GS1 defines trade items as products or services that are priced, ordered or invoiced at any point in the supply chain.
GTIN once assigned to a trade item, it provides a common language for all of its entities and trading partners worldwide to uniquely identify the item and easily communicate information about the item.
Track & Trace Program is the current EIPICO's Project with
the mission that all packaging lines will be provided by
DataMatrix Systems.
This is being worked on nowadays and will be accomplished by 2020.
Company Profile | 2020
The Biotechnology Center was established in 2000 with the mission of being the First Facility in Egypt capable of producing Biopharmaceutical Drug Substances and Drug Products by applying and implementing all the required state-of-the-art techniques:
USP: Tissue Culture, Fermentation.DSP: Affinity, IEX, Size Exclusion, TFF, Ultra-FiltrationAnalysis: SDS-PAGE Electrophoresis, Isoelectric Focusing, Western Blot, Peptide mapping, RT-PCR, BioAssay, ELISA.
The Biotechnology Center now produces rh- Erythropoietin Hormone which is marketed under the name of EPOFORM 2000 IU/ml and EPOFORM 4000 IU/ml.
EIPICO has the First Biotechnology and Genetic Engineering Research
Center in Egypt.Biotechnology Center
Company Profile | 2020Company Profile | 2020
We believe in continuous discovery, improvement and creativity; that’s why we invest annually in
our R&D labs to bring the state-of-the-art equipment for formulation, characterization and analytical
activities.
Our R&D team serves in two major trends:
1. The Productive trend which is exhibited in all lab scale trials and scale-up activities of all
pharmaceutical dosage forms.
2. The Responsive trend manifested in troubleshooting of production, non-conforming reports
and stability problems.
Our R&D team, is the spearhead of our company to maintain a cutting edge performance in nowadays fierce competition and to keep up with the era of global progress and sustainable developments.
Research & Development
Company Profile | 2020
Quality Control
We foster a quality control culture based on:
Highly-qualified/proactive personnel.
An environment of continuous improvement.
Robust and standardized laboratory that utilizes the most cutting-edge instrumentation
and methodologies to provide the most precise and accurate results, with ALL our
testing being done "In-house".
Company Profile | 2020
Quality AssuranceEvery member in our team has a significant role to play in order to achieve our mission
successfully by bringing high quality pharmaceutical products to the Egyptian and
International markets.
We are certain that our values are embedded in our culture and our decision making helps
us to meet the expectations of the society.
We encourage associates to achievement through organized collaboration. Consequently,
our quality members are provided with the right decision making authority giving a
guarantee for short decision routes.
Company Profile | 2020
The aim of EIPICO Pharmacovigilance Department is to enhance patient's health
and safety in relation to the use of EIPICO products through providing reliable, and
balanced information to ensure that the overall benefits of medicines outweigh the
risks.
Such aim is fulfilled by collecting Adverse Drug Reaction Reports/Customer
Complaints and preparing Pharmacovigilance documents for each of EIPICO
marketed products routinely, to assess the medicines Benefit/Risk balance.
Thus, by reporting Adverse Drug Reactions/Complaints witnessed from a drug, we
share in the continuous monitoring of the safety, efficacy and quality of the drug
beside ensuring that the Benefit/Risk balance is updated in order to reach safer
medicinal products and have a positive impact on the public safety/health.
PharmacovigilanceReport… Your Report Counts.
Safety First
Company Profile | 2020
Plastic FactoryThe main goal of establishing the factory was far beyond achieving any financial gain, but
only to maintain the high quality level of EIPICO's Eye Drops assuring the sterility of the
medicament all through the production process up to the end user.
This target was not achievable regarding the low quality of the locally-produced eye drops
bottles.
Since the beginning and up till now, the factory covered all EIPICO's needs of Eye Drops
Dropper Bottles, Sizes: 5, 10, and 15 ml, with a quality level that matches the highest
international standards, and was capable of developing its productivity to fulfill future needs.
Company Profile | 2020
EIPICO decided to establish affiliated factories, in the field of industries feeding the
pharmaceutical industries, to ensure the constant and sufficient availability of primary
packaging materials, and to avoid the problems of import (shipping and foreign
currencies).
In 2005, Egyptian International Ampoules Company - EIACO was established, as an
Egyptian investment company for manufacturing medical ampoules, over the area of 25
thousand square meters in the 10th of Ramadan City. EIPICO is the main investor.
Affiliate
CompanyEIACOEgyptian International Ampoules Company
Company Profile | 2020
Current Production:
120 Million Vials of Type 1 Vial per year.
33 Million Aluminum Tubes for the filling of Skin and Eye Ointments.
EIACO is currently the Largest Manufacturer of Primary
Packaging Materials in Egypt, managing to completely
secure the needs of EIPICO from Ampoules, Vials
and Aluminum Tubes, which is a great success
in achieving the strategic objective of its establishment.
EIACOEgyptian International Ampoules Company
Affiliate
Company
EIACO has been accredited the ISO 9001/2015 Quality Certificate.
Company Profile | 2020
Alliances
EIPICO has production and
under license agreements
with many multinational
companies.
They all trust our quality
standards, experience and
capabilities.
Altiazem Tablets
Tebonina Forte Tablets
Lactulose Hek Syrup
Tantum Verde Mouth Wash & Gargle
Tantum Rosa Vaginal Powder
Tantum Cream Forte & Gel
Ibutop Gel
Balkis Drops
Librax Tablets
Norgesic Tablets
Norflex Tablets & Ampoules
Company Profile | 2020
Commitment
EIPICO strengthened global access through partnership and collaboration with international health ministries in tender-based institutional business
Strategy
EIPICO is committed to reach global patients through partnership with local pharmaceutical importers and distributors.
Coverage
EIPICO serves global patients in majority essential therapeutic classes with about 1300 different product files registered worldwide.
Capacity
EIPICO exports about 25% of it’s production capacity.
EXPORTWe Think Globally
Company Profile | 2020
1987
20102018
2020
EIPICO started Export to Middle East and North Africa (MENA) region.
EIPICO was able to penetrate Eastern Europe countries,including C.I.S. countries.
EIPICO increased global access to reach 40 countries.
EIPICO continued serving global patients and reached 65 countries.
EIPICO's Expansion Plan is targeting 15 more countries by 2022.
19921997
19982010
Timeline Progress
EXPORTWe Think Globally
Company Profile | 2020
Rank 1
We Think Globally
EIPICO strongly believes in access to high
quality affordable priced medicines is a basic
human right and we are committed to our
vision through.
“EIPICO captures
21% of Egypt’s Total Exports
of Pharmaceutical
Products, by value.
(2019)
in Egyptian Exports of Pharmaceutical Products.
EXPORT
Company Profile | 2020
EXPORTWe Think Globally
EIPICO exports cover
65countries
in the Middle East, Africa,
Europe, Far East and
Latin America
EIPICO expansion plan targets
15 more countries by 2022.
Company Profile | 2020
The FUTURE…
As a continuation of the company's pioneer role in developing the
pharmaceutical industry and providing the necessary high quality
medications of suitable prices to the Egyptian citizens,
EIPICO is studying the manufacturing of Biosimilars in Egypt, with
investments of up to One Billion Egyptian pounds, to produce drugs
for the treatment of cancer, as well as, hormones.Chief Executive Officer
Contact us
Tenth of RamadanAddress: EIPICO, Tenth of Ramadan City - 1st Industrial Zone B1, Egypt.Telephone: +20554499199. Fax: +20554499306.E-mail: eipico@eipico.com.eg
Commercial Sector E-mail: CommercialSector@eipico.netExport Sector E-mail: ExportSector@eipico.netFinancial Sector E-mail: FinancialSector@eipico.netProduction Sector E-mail: ProductionSector@eipico.netQuality Sector E-mail: QualitySector@eipico.net
Company Profile | 2020
Yes We Care
Contact us
Cairo & Giza BranchesAddress: 3, El Moez Ledin Allah St. from Asmaa Fahmy St., Ard El Golf, Nasr City, Cairo.Tel: 0224143660 & 0224143550E-mail: cairo@eipico.netE-mail: giza@eipico.net
Alexandria BranchAddress: New Mansheya - Muharram Bek - Bridges Highway - The Land of Alexandria Refrigeration Company.Tel: 03 3600612 - 03 3600615 - 03 3600616 - 03 3600618E-mail: alex@eipico.net
Tanta BranchAddress: Mohamed Farid St., Off Hassan Radwan St., Tanta.Tel: 040 / 3325924 - 040 / 3325926E-mail: tanta@eipico.net
Sohag BranchAddress: Rawafie Al-Kousair, Sohag.Tel: 093 2334652E-mail: sohag@eipico.net
Banha BranchAddress: 63, Banha El Zagazig Rd., Qism Banha, Qalyubia.Tel: 013 3229020 - 01220700406 - 01220700408E-mail: banha@eipico.net
Menia BranchAddress: Stores and Warehouses “Development and Agricultural Credit Bank” - First railway Telah - Minya.Tel: 086 2351480 - 086 2351474E-mail: menia@eipico.net
Mansoura BranchAddress: 13, El-Emam El Ghazali St., Toreil, El Mansoura Second, Dakahlia.Tel: 050 2328811E-mail: mansora@eipico.net
Yes We Care
Tenth of Ramadan BranchTenth of Ramadan City - Industrial Area B 1 (Factory 1 and Factory 2)0554499199 & Fax: 0554499306tenth@eipico.net
Branches
Company Profile | 2020
top related